Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Autor: Bleecker, Eugene R, FitzGerald, J Mark, Chanez, Pascal, Papi, Alberto, Weinstein, Steven F, Barker, Peter, Sproule, Stephanie, Gilmartin, Geoffrey, Aurivillius, Magnus, Werkström, Viktoria, Goldman, Mitchell
Zdroj: In The Lancet 29 October-4 November 2016 388(10056):2115-2127
Databáze: ScienceDirect